TOKYO - The coverage rate of maternal vaccination against respiratory syncytial virus stood at 11.6 percent in Japan due to the high out-of-pocket payment and a lack of awareness following its introduction in the country in May 2024, according to a national health institute.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
Related coverage:
